Stay updated on MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments
Sign up to get notified when there's something new on the MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments page.

Latest updates to the MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments page
- Check4 days agoChange DetectedThe clinical trial record for a Phase 2 study of pembrolizumab-based treatments in Stage IV MSI-H or dMMR colorectal cancer is now displayed instead of an access-denied page. It includes trial status, treatment arms, eligibility details, study outcomes, and participating locations.SummaryDifference100%

- Check11 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1 while the study page continued to display a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, indicating the study record is currently inaccessible; previously visible study details have been removed.SummaryDifference20%

- Check60 days agoChange DetectedThe page now shows a new revision tag: v3.7.0, replacing the previous v3.6.6. This updates the page's metadata/version indicator rather than altering the study details or content.SummaryDifference0.0%

Stay in the know with updates to MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments
Enter your email address, and we'll notify you when there's something new on the MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments page.